ArticleMedical decision making : an international journal of the Society for Medical Decision Making2026
Did You Know That Confounding Could Bias Results Obtained within an Economic Evaluation?
Article in Medical decision making : an international journal of the Society for Medical Decision Making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe increasing use of real-world data in economic evaluation raises concerns about the potential for confounding bias. Methods to control for this bias have been developed, but there is still much to be understood about how confounding influences economic evaluations.
objectivesTo illustrate the impact of unadjusted confounding variables in economic evaluations of observational studies.
methodsWe simulated the costs and effectiveness of 2 treatments across 9 possible confounding effect scenarios. We considered these scenarios in the context in which one treatment is more costly and more effective with mild correlation between confounders and outcomes. All scenarios examined the incremental cost and effectiveness of 400 randomly generated individuals, reflecting sample sizes commonly seen within observational economic evaluations. Results were illustrated with the use of cost-effectiveness planes and cost-effectiveness acceptability curves (CEAC).
resultsOur simulations illustrate that confounding bias can have a significant effect on incremental costs and incremental effectiveness estimates. These simulations also illustrate that confounders can affect the evaluation of uncertainty by causing a shift in the CEACs. Such results hint that inadequate consideration of confounding bias can potentially lead to flawed judgments about the cost-effectiveness of a treatment. DISCUSSION: Results of economic evaluations can be influenced by confounding when they are conducted in an observational setting. Efforts must be made to limit their impact to ensure an accurate assessment of the economic value of treatments and to prevent potential losses of population health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.